MC
FMI

Maplelane Capital’s Foundation Medicine, Inc. FMI Stock Holding History

Maplelane Capital’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-133,000
Closed -$3.17M – 215
2013
Q4 		$3.17M Buy
+133,000
New +$3.72M 0.13% 102

Other funds holding FMI

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCM
Cupps Capital Management Chicago, Illinois $231M AUM 49.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Maplelane Capital's FMI Position: Q1 2014 in Review

Maplelane Capital sold out of Foundation Medicine, Inc. (FMI) in Q1 2014, closing a stake of 133,000 shares — an estimated $3.17M sold.

Maplelane Capital first reported a position in FMI in Q4 2013 and held it in 1 quarter. The position peaked at $3.17M in Q4 2013. 90 funds tracked by Wall St. Rank hold FMI as of Q1 2014.

  • Maplelane Capital reported no remaining Foundation Medicine, Inc. position as of Q1 2014 after selling out during the quarter.
  • Maplelane Capital sold 133,000 Foundation Medicine, Inc. shares in Q1 2014, an estimated $3.17M.
  • Maplelane Capital first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 1 quarter.
  • Maplelane Capital's Foundation Medicine, Inc. position peaked at $3.17M in Q4 2013.
  • 90 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2014.

Based on Maplelane Capital's 13F filing for Q1 2014, filed 15 May 2014.